Reliable determination of fetal RhD status by RHD genotyping from maternal plasma

Transfusion Medicine and Hemotherapy

Volumn 40, Issue 1, 2013, Pages 37-43

  Dovč Drnovšek, Tadeja ^a   Klemenc, Polona ^a   Toplak, Nataša ^b   Blejec, Tanja ^c   Bricl, Irena ^a   Rožman, Primož ^a  

^a BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

^b Iskra Feriti doo   (Slovenia)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Fetal DNA; Maternal plasma; Noninvasive RHD typing

Indexed keywords

RHESUS D ANTIGEN; TESTIS DETERMINING FACTOR;

ALLOIMMUNIZATION; ARTICLE; DNA EXTRACTION; EXON; FEMALE; FETUS; GENOTYPE; GESTATIONAL AGE; HUMAN; INTRON; MALE; MATERNAL PLASMA; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PREGNANCY; REAL TIME POLYMERASE CHAIN REACTION; CONTROLLED STUDY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SRY GENE;

EID: 84874374425     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000345682     Document Type: Article

References (39)

1. Mollison PL, Engelfriet CP, Contreras M: Blood Transfusion in Clinical Medicine, 10th ed. Oxford, Blackwell Science Ltd., 1997.
2. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, Poon PM, Redman CW, Wainscoat JS: Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-1738.
3. Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K, Dickmeiss E, Hedegaard M, Dziegiel MH: Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenat Diagn 2005;25:1040-1044.
4. Engelfriet CP, Reesink HW, Judd WJ, Ulander VM, Kuosmanen M, Koskinen S, Rouger P, More-lati F, Tantalo V, Fujii T, de HM, van der Schoot CE, Overbeeke M, Koelewijn J, Bonsel G, Vrij-kotte T, Zupanska B, Martin-Vega C, Parra LR, de SM, Contreras M, Panzer S, Ulm B, Mayr WR: Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sang 2003;85:328-337.
5. Flegel WA, Wagner FF: Molecular genetics of RH. Vox Sang 2000;78(suppl 2):109-115.
6. Mackenzie IZ, Roseman F, Findlay J, Thompson K, Jackson E, Scott J, Reed M: The kinetics of routine antenatal prophylactic intramuscular injections of polyclonal anti-D immunoglobulin. BJOG 2006; 113:97-101.
7. Daniels G: Human Blood Groups, 2nd ed. Oxford, Blackwell Science Ltd, 2002.
8. Van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-Christiaens LG, de Haas M: Non-invasive antenatal RHD typing. Transfus Clin Biol 2006;13:53-57.
9. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS: Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487.
10. Daniels G, Finning K, Martin P, Massey E: Nonin-vasive prenatal diagnosis of fetal blood group phe-notypes: current practice and future prospects. Pre-nat Diagn 2009;29:101-107.
11. Finning KM, Martin PG, Soothill PW, Avent ND: Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD geno-typing service. Transfusion 2002;42:1079-1085.
12. Kolialexi A, Tounta G, Mavrou A: Noninvasive fetal RhD genotyping from maternal blood. Expert Rev Mol Diagn 2010;10:285-296.
13. Daniels G, van der Schoot CE, Olsson ML: Report of the First International Workshop on molecular blood group genotyping. Vox Sang 2005;88:136-142.
14. Daniels G, van der Schoot CE, Olsson ML: Report of the fourth International Workshop on molecular blood group genotyping. Vox Sang 2011;101:327-332.
15. Legler TJ, Liu Z, Mavrou A, Finning K, Hromad-nikova I, Galbiati S, Meaney C, Hulten MA, Crea F, Olsson ML, Maddocks DG, Huang D, Fisher SA, Sprenger-Haussels M, Soussan AA, van der Schoot CE: Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn 2007;27:824-829.
16. Clausen FB, Christiansen M, Steffensen R, Jor-gensen S, Nielsen C, Jakobsen MA, Madsen RD, Jensen K, Krog GR, Rieneck K, Sprogoe U, Homburg KM, Grunnet N, Dziegiel MH: Report of the first nationally implemented clinical routine screening for fetal RHD in D-pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 2012;52:752-758.
17. Scheffer PG, de Haas M, van der Schoot CE: The controversy about controls for fetal blood group genotyping by cell-free fetal DNA in maternal plasma. Curr Opin Hematol 2011;18:467-473.
18. Houfflin-Debarge V, O'Donnell H, Overton T, Bennett PR, Fisk NM: High sensitivity of fetal DNA in plasma compared to serum and nucleated cells using unnested PCR in maternal blood. Fetal Diagn Ther 2000;15:102-107.
19. Lam NY, Rainer TH, Chiu RW, Lo YM: EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis. Clin Chem 2004;50:256-257.
20. Muller SP, Bartels I, Stein W, Emons G, Gutensohn K, Kohler M, Legler TJ: The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 2008;48:2292-2301.
21. Muller SP, Bartels I, Stein W, Emons G, Gutensohn K, Legler TJ: Cell-free fetal DNA in specimen from pregnant women is stable up to 5 days. Prenat Diagn 2011;31:1300-1304.
22. Rijnders RJ, Christiaens GC, Bossers B, van der Smagt JJ, van der Schoot CE, de Haas M: Clinical applications of cell-free fetal DNA from maternal plasma. Obstet Gynecol 2004;103:157-164.
23. Chiu RW, Poon LL, Lau TK, Leung TN, Wong EM, Lo YM: Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001;47:1607-1613.
24. Clausen FB, Krog GR, Rieneck K, Dziegiel MH: Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit. Prenat Diagn 2007;27:6-10.
25. Horlitz M, Hartinger T, Graf S, Lucas A, Nocon A, Sprenger-Haussels M: Yields of viral and circulating cell-free nucleic acids using the QIAamp Circulating Nucleic Acid Kit; in Gahan PB (ed): Circulating Nucleic Acids in Plasma and Serum. Dordrecht, Springer Netherlands, 2011, pp. 259-268.
26. Legler TJ, Muller SP, Haverkamp A, Grill S, Hahn S: Prenatal RhD testing: a review of studies published from 2006 to 2008. Transfus Med Hemother 2009;36:189-198.
27. Colin Y, Cherif-Zahar B, Le Van KC, Raynal V, Van H, V, Cartron JP: Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991;78:2747-2752.
28. Singleton BK, Green CA, Avent ND, Martin PG, Smart E, Daka A, Narter-Olaga EG, Hawthorne LM, Daniels G: The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95:12-18.
29. Metcalfe P, Rigsby P, Tait E, Urbaniak S: An international reference reagent for the detection of RHD and SRY DNA in plasma. Vox Sang 2011.
30. Rouillac-Le Sciellour C, Puillandre P, Gillot R, Baulard C, Metral S, Le Van KC, Cartron JP, Colin Y, Brossard Y: Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol Diagn 2004;8:23-31.
31. Avent ND: RHD genotyping from maternal plasma: guidelines and technical challenges. Methods Mol Biol 2008;444:185-201.
32. Sbarsi I, Isernia P, Montanari L, Badulli C, Marti-netti M, Salvaneschi L: Implementing non-invasive RHD genotyping on cell-free foetal DNA from maternal plasma: the Pavia experience. Blood Transfus 2012;10:34-38.
33. Dovã-Drnovšek T, Toplak N, Bricl I, Blejec T, Kovaã M, Rožman P: An additional pre-amplification step for the early determination of fetal RHD from maternal plasma; in Gahan PB (ed): Circulating Nucleic Acids in Plasma and Serum. Dordrecht, Springer Netherlands, 2011, pp. 147-151.
34. Alizadeh M, Bernard M, Danic B, Dauriac C, Bire-bent B, Lapart C, Lamy T, Le Prise PY, Beauplet A, Bories D, Semana G, Quelvennec E: Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002;99: 4618-4625.
35. Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA: Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features. Blood 1998;91: 2157-2168.
36. Daniels G, van der Schoot CE, Olsson ML: Report of the Second International Workshop on molecular blood group genotyping. Vox Sang 2007;93:83-88.
37. Daniels G, van der Schoot CE, Gassner C, Olsson ML: Report of the third international workshop on molecular blood group genotyping. Vox Sang 2009; 96:337-343.
38. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G: Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008;336:816-818.
39. Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM: Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion 2008;48:373-381.